PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. Stock
Heavy losses for PTC Therapeutics Inc. today as the stock fell by -€1.200 (-3.410%).
Currently there is a rather positive sentiment for PTC Therapeutics Inc. with 15 Buy predictions and 7 Sell predictions.
With a target price of 41 € there is a positive potential of 20.59% for PTC Therapeutics Inc. compared to the current price of 34.0 €.
Our community identified positive and negative aspects for PTC Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the PTC Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
PTC Therapeutics Inc. | -3.410% | 13.333% | 45.299% | -12.821% | 34.921% | 8.280% | -1.862% |
Ironwood Pharmaceuticals | -7.500% | -4.310% | -25.503% | -44.221% | -45.588% | -45.050% | - |
Novocure Ltd | 4.840% | 5.435% | 89.436% | -71.271% | 49.492% | -85.644% | - |
Iovance Biotherapeutics Inc. | -2.500% | -2.040% | -15.627% | 22.927% | 18.110% | -36.836% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $18.00 to $26.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat